Exact Sciences
EXAS
#1154
Rank
โ‚ฌ16.47 B
Marketcap
86,80ย โ‚ฌ
Share price
-0.07%
Change (1 day)
46.83%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Market capitalization of Exact Sciences (EXAS)

Market cap: โ‚ฌ16.47 Billion

As of December 2025 Exact Sciences has a market cap of โ‚ฌ16.47 Billion. This makes Exact Sciences the world's 1154th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Exact Sciences from 2001 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ16.47 B60.93%
2024โ‚ฌ10.23 B-15.43%
2023โ‚ฌ12.10 B47.58%
2022โ‚ฌ8.20 B-31.29%
2021โ‚ฌ11.93 B-26.34%
2020โ‚ฌ16.20 B32.95%
2019โ‚ฌ12.18 B79.35%
2018โ‚ฌ6.79 B29.61%
2017โ‚ฌ5.24 B280.75%
2016โ‚ฌ1.37 B68.73%
2015โ‚ฌ0.81 B-59.19%
2014โ‚ฌ1.99 B230.67%
2013โ‚ฌ0.60 B18.18%
2012โ‚ฌ0.51 B54.6%
2011โ‚ฌ0.33 B41.12%
2010โ‚ฌ0.23 B179.01%
2009โ‚ฌ84.05 M656.59%
2008โ‚ฌ11.1 M-81.44%
2007โ‚ฌ59.85 M4.21%
2006โ‚ฌ57.43 M16.45%
2005โ‚ฌ49.32 M-33.54%
2004โ‚ฌ74.21 M-52.18%
2003โ‚ฌ0.15 B-21.45%
2002โ‚ฌ0.19 B-9.25%
2001โ‚ฌ0.21 B

End of Day market cap according to different sources

On Dec 6th, 2025 the market cap of Exact Sciences was reported to be:

โ‚ฌ16.44 Billion
by Nasdaq info icon info icon
โ‚ฌ16.47 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Myriad Genetics
MYGN
โ‚ฌ0.56 B-96.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
โ‚ฌ0.82 B-95.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Veracyte
VCYT
โ‚ฌ3.02 B-81.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
โ‚ฌ0.98 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ103.84 B 530.41%๐Ÿ‡ซ๐Ÿ‡ท France